Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies
Mohammad Shadid(Roivant Sciences (United States)), Punam Malik(Cincinnati Children's Hospital Medical Center)
Cited by 3
Related Papers
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
|Blood|2004|184
Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study
|Blood Advances|2020|56
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
|Gene Therapy|2021|39
Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment
|JCI Insight|2022|16
Mechanism of Human Hematopoietic Stem Cell Loss during Ex Vivo Manipulation and Gene Transfer
|Experimental Hematology|2018|0